Discovery Labs inks development deal for therapy targeting premature infants

Discovery Laboratories Inc. has found a development partner for a potentially improved version of its drug used to prevent respiratory distress syndrome in infants born prematurely...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.